Abstract
Depression or major depressive disorder (MDD) is a disease that is characterized by prolonged sad mood. In most of the cases, the disorder is presented with other comorbid illnesses such as anxiety, Alzheimer’s disease (AD), obesity, and diabetes. Most of the drugs used for the treatment are targeting the levels of monoamines, namely serotonin, dopamine, and norepinephrine in the synapse. Most of the drugs showed their effect after 4–6 weeks of treatment as they are working via modification of receptors. In addition, adverse effects, treatment resistance, and poor outcomes of the available treatment have urged the need for novel and promising therapeutic options. Exosomes are extracellular vesicles (EVs) of endocytic origin. These vesicles are secreted or released by cells and found in bio-fluids such as urine, plasma, and saline. These vesicles are having a role in various vital processes of the body and are made up of small RNA, DNA, and proteins. These vesicles may play an important role in various physiological processes such as cell-to-cell communication, neurogenesis, and synaptic plasticity. One of the important advantages of exosomes is that they are able to cross blood–brain barrier (BBB). Moreover, exosomes are capable of transferring DNA, protein, mRNAs, and miRNAs to recipient cells. This chapter enlightens the potential role of exosomes in MDD and their utilization as a therapeutic option or diagnostic tool for depression.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahmad S, Srivastava RK, Singh P, Naik UP, Srivastava AK (2022) Role of extracellular vesicles in glia-neuron intercellular communication. Front Mol Neurosci 15:844194
Aili Y, Maimaitiming N, Mahemuti Y, Qin H, Wang Y, Wang Z (2021) The role of exosomal miRNAs in glioma: biological function and clinical application. Front Oncol 11:686369
Bălașa A, Șerban G, Chinezu R, Hurghiș C, Tămaș F, Manu D (2020) The involvement of exosomes in glioblastoma development, diagnosis, prognosis, and treatment. Brain Sci 10(8):553
Banks WA (2009) Characteristics of compounds that cross the blood-brain barrier. BMC Neurol 9(Suppl 1):S3
Bareford LM, Swaan PW (2007) Endocytic mechanisms for targeted drug delivery. Adv Drug Deliv Rev 59(8):748–758
Behzadi S, Serpooshan V, Tao W, Hamaly MA, Alkawareek MY, Dreaden EC et al (2017) Cellular uptake of nanoparticles: journey inside the cell. Chem Soc Rev 46(14):4218–4244
Benazzi F (2006) Various forms of depression. Dialogues Clin Neurosci 8(2):151–161
Beutel ME, Jünger C, Klein EM, Wild P, Lackner K, Blettner M et al (2016) Noise annoyance is associated with depression and anxiety in the general population- the contribution of aircraft noise. PLoS One 11(5):e0155357
Bhatt S, Nagappa AN, Patil CR (2020) Role of oxidative stress in depression. Drug Discov Today 25(7):1270–1276
Bhatt S, Devadoss T, Manjula SN, Rajangam J (2021a) 5-HT(3) receptor antagonism a potential therapeutic approach for the treatment of depression and other disorders. Curr Neuropharmacol 19(9):1545–1559
Bhatt S, Kanoujia J, Dhar AK, Arumugam S, Silva AKA, Mishra N (2021b) Exosomes: a novel therapeutic paradigm for the treatment of depression. Curr Drug Targets 22(2):183–191
Bhatt S, Devadoss T, Jha NK, Baidya M, Gupta G, Chellappan DK et al (2023 Jan) Targeting inflammation: a potential approach for the treatment of depression. Metab Brain Dis 38(1):45–59
Blumberger DM, Hsu JH, Daskalakis ZJ (2015) A review of brain stimulation treatments for late-life depression. Curr Treat Options Psychiatry [Internet] 2(4):413–421. https://doi.org/10.1007/s40501-015-0059-0
Breijyeh Z, Karaman R (2020) Comprehensive review on Alzheimer’s Disease: causes and treatment. Molecules 25(24):5789
Brigitta B (2002) Pathophysiology of depression and mechanisms of treatment. Dialogues Clin Neurosci 4(1):7–20
Cai Y, Liu J, Wang B, Sun M, Yang H (2022) Microglia in the neuroinflammatory pathogenesis of Alzheimer’s disease and related therapeutic targets. Front Immunol 13:856376
Cherian A, Thomas SV (2011) Central nervous system tuberculosis. Afr Health Sci 11(1):116–127
Ching RC, Kingham PJ (2015) The role of exosomes in peripheral nerve regeneration. Neural Regen Res 10(5):743–747
Dando SJ, Mackay-Sim A, Norton R, Currie BJ, St John JA, Ekberg JAK et al (2014) Pathogens penetrating the central nervous system: infection pathways and the cellular and molecular mechanisms of invasion. Clin Microbiol Rev 27(4):691–726
Daneman R, Prat A (2015 Jan) The blood-brain barrier. Cold Spring Harb Perspect Biol 7(1):a020412
Doyle LM, Wang MZ (2019) Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells 8(7):727
Duman RS, Sanacora G, Krystal JH (2019) Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments. Neuron 102(1):75–90
Felger JC, Lotrich FE (2013) Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience 246:199–229
Fries GR, Saldana VA, Finnstein J, Rein T (2023) Molecular pathways of major depressive disorder converge on the synapse. Mol Psychiatry [Internet] 28(1):284–297. https://doi.org/10.1038/s41380-022-01806-1
Gorman JM (1996) Comorbid depression and anxiety spectrum disorders. Depress Anxiety 4(4):160–168
Grabrucker AM, Ruozi B, Belletti D, Pederzoli F, Forni F, Vandelli MA et al (2016) Nanoparticle transport across the blood brain barrier. Tissue barriers 4(1):e1153568
Grover S, Dutt A, Avasthi A (2010) An overview of Indian research in depression. Indian J Psychiatry 52(Suppl 1):S178–S188
Gu S, He Z, Xu Q, Dong J, **ao T, Liang F et al (2022) The relationship between 5-hydroxytryptamine and its metabolite changes with post-stroke depression. Front Psych 13:871754
Hade MD, Suire CN, Suo Z (2021) Mesenchymal stem cell-derived exosomes: applications in regenerative medicine. Cells 10(8):1959
Hervé F, Ghinea N, Scherrmann JM (2008) CNS delivery via adsorptive transcytosis. AAPS J 10(3):455–472
Huda MN, Nafiujjaman M, Deaguero IG, Okonkwo J, Hill ML, Kim T et al (2021) Potential use of exosomes as diagnostic biomarkers and in targeted drug delivery: progress in clinical and preclinical applications. ACS Biomater Sci Eng 7(6):2106–2149
Hwang S, Yang YM (2021) Exosomal microRNAs as diagnostic and therapeutic biomarkers in non-malignant liver diseases. Arch Pharm Res 44(6):574–587
Janigro D, Bailey DM, Lehmann S, Badaut J, O’Flynn R, Hirtz C, Marchi N (2021) Peripheral blood and salivary biomarkers of blood-brain barrier permeability and neuronal damage: clinical and applied concepts. Front Neurol 11:577312
Jiang L, Dong H, Cao H, Ji X, Luan S, Liu J (2019) Exosomes in pathogenesis, diagnosis, and treatment of Alzheimer’s disease. Med Sci Monit Int Med J Exp Clin Res 25:3329–3335
Kalluri R, LeBleu VS (2020) The biology, function, and biomedical applications of exosomes. Science 367(6478):eaau6977
Karrouri R, Hammani Z, Benjelloun R, Otheman Y (2021) Major depressive disorder: validated treatments and future challenges. World J Clin Cases 9(31):9350–9367
Keller J, Gomez R, Williams G, Lembke A, Lazzeroni L, Murphy GMJ et al (2017) HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition. Mol Psychiatry 22(4):527–536
Koepsell H (2020) Glucose transporters in brain in health and disease. Pflugers Arch 472(9):1299–1343
Lee JY, Kim HS (2017) Extracellular vesicles in neurodegenerative diseases: a double-edged sword. Tissue Eng Regen Med 14(6):667–678
Li N, Shu J, Yang X, Wei W, Yan A (2022) Exosomes derived from M2 microglia cells attenuates neuronal impairment and mitochondrial dysfunction in alzheimer’s disease through the PINK1/parkin pathway. Front Cell Neurosci 16:874102
Lin Z, Gu Y, Zhou R, Wang M, Guo Y, Chen Y et al (2020) Serum exosomal proteins F9 and TSP-1 as potential diagnostic biomarkers for newly diagnosed epilepsy. Front Neurosci 14:737
Liu W, Bai X, Zhang A, Huang J, Xu S, Zhang J (2019) Role of exosomes in central nervous system diseases. Front Mol Neurosci 12:240
Mavroeidi P, Vetsi M, Dionysopoulou D, **louri M (2022) Exosomes in alpha-synucleinopathies: propagators of pathology or potential candidates for nanotherapeutics? Biomol Ther 12(7)
Mittal R, Chourasia N, Bharti VK, Singh S, Sarkar P, Agrawal A et al (2022) Blood-based biomarkers for diagnosis, prognosis, and severity prediction of COVID-19: opportunities and challenges. J Fam Med Prim care 11(8):4330–4341
Naschberger E, Lubeseder-Martellato C, Meyer N, Gessner R, Kremmer E, Gessner A et al (2006) Human guanylate binding protein-1 is a secreted GTPase present in increased concentrations in the cerebrospinal fluid of patients with bacterial meningitis. Am J Pathol 169(3):1088–1099
Pardridge WM (2012) Drug transport across the blood-brain barrier. J Cereb Blood Flow Metab 32(11):1959–1972
Pinnell JR, Cui M, Tieu K (2021 May) Exosomes in Parkinson disease. J Neurochem 157(3):413–428
Rădulescu I, Drăgoi AM, Trifu SC, Cristea MB (2021 Oct) Neuroplasticity and depression: rewiring the brain’s networks through pharmacological therapy (review). Exp Ther Med 22(4):1131
Rajput A, Varshney A, Bajaj R, Pokharkar V (2022) Exosomes as new generation vehicles for drug delivery: biomedical applications and future perspectives. Molecules 27(21):7289
Saeed SA, Antonacci DJ, Bloch RM (2010) Exercise, yoga, and meditation for depressive and anxiety disorders. Am Fam Physician 81(8):981–986
Saeedi S, Israel S, Nagy C, Turecki G (2019 Mar) The emerging role of exosomes in mental disorders. Transl Psychiatry 9(1):122
Sheng K, Lu X, Yue J, Gu W, Gu C, Zhang H et al (2019) Role of neurotransmitters 5-hydroxytryptamine and substance P in anorexia induction following oral exposure to the trichothecene T-2 toxin. Food Chem Toxicol [Internet] 123:1–8. Available from: https://www.sciencedirect.com/science/article/pii/S0278691518307749
Shetgaonkar GG, Marques SM, DCruz CEM, Vibhavari RJA, Kumar L, Shirodkar RK (2022) Exosomes as cell-derivative carriers in the diagnosis and treatment of central nervous system diseases. Drug Deliv Transl Res 12(5):1047–1079
Shetty T, Raince A, Manning E, Tsiouris AJ (2016) Imaging in chronic traumatic encephalopathy and traumatic brain injury. Sports Health 8(1):26–36
Sowers JL, Wu P, Zhang K, DeWitt DS, Prough DS (2018) Proteomic changes in traumatic brain injury: experimental approaches. Curr Opin Neurol 31(6):709–717
Stefanis L (2012) α-Synuclein in Parkinson’s disease. Cold Spring Harb Perspect Med 2(2):a009399
Stewart JW, McGrath PJ, Quitkin FM, Klein DF (2009) DSM-IV depression with atypical features: is it valid? Neuropsychopharmacology [Internet] 34(13):2625–2632. https://doi.org/10.1038/npp.2009.99
Sun YF, Pi J, Xu JF (2021) Emerging role of exosomes in tuberculosis: from immunity regulations to vaccine and immunotherapy. Front Immunol 12:628973
Szepesi Z, Manouchehrian O, Bachiller S, Deierborg T (2018) Bidirectional microglia-neuron communication in health and disease. Front Cell Neurosci 12:323
Thomas SC, Kim JW, Pauletti GM, Hassett DJ, Kotagiri N (2021) Exosomes: biological pharmaceutical nanovectors for theranostics. Front Bioeng Biotechnol 9:808614
Upadhyay RK (2014) Transendothelial transport and its role in therapeutics. Int Sch Res Not 2014:309404
Walsh RB, Dresselhaus EC, Becalska AN, Zunitch MJ, Blanchette CR, Scalera AL, Lemos T, Lee SM, Apiki J, Wang S, Isaac B, Yeh A, Koles K, Rodal AA (2021) Opposing functions for retromer and Rab11 in extracellular vesicle traffic at presynaptic terminals. J Cell Biol 220(8):e202012034
Xu M, Feng T, Liu B, Qiu F, Xu Y, Zhao Y et al (2021) Engineered exosomes: desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies. Theranostics 11(18):8926–8944
Yang T, Martin P, Fogarty B, Brown A, Schurman K, Phipps R et al (2015) Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio. Pharm Res 32(6):2003–2014
Zimta AA, Baru O, Badea M, Buduru SD, Berindan-Neagoe I (2019) The role of angiogenesis and pro-angiogenic exosomes in regenerative dentistry. Int J Mol Sci 20(2):406
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Nigade, A., Pathak, G., Anitha, K., Mishra, N., Bali, V., Bhatt, S. (2024). Role of Exosomes in Management of Depression. In: Mishra, N., Ashique, S., Garg, A., Chithravel, V., Anand, K. (eds) Exosomes Based Drug Delivery Strategies for Brain Disorders. Springer, Singapore. https://doi.org/10.1007/978-981-99-8373-5_8
Download citation
DOI: https://doi.org/10.1007/978-981-99-8373-5_8
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-8372-8
Online ISBN: 978-981-99-8373-5
eBook Packages: MedicineMedicine (R0)